DNA polymerase η inhibitors represent a multifaceted class of chemical entities meticulously designed to intricately disrupt the nuanced functionality of DNA polymerase η, a specialized member of the DNA polymerase family. This unique polymerase assumes a critical role in the cellular defense against ultraviolet (UV) radiation-induced DNA damage by proficiently replicating past thymine-thymine dimers, aberrant DNA lesions that can result in mutations if not accurately repaired. The finesse of these inhibitors lies in their capacity to precisely target DNA polymerase η while sparing other polymerases essential for normal DNA replication and repair. The mechanisms underlying the interaction between these inhibitors and DNA polymerase η are multifunctional and strategic. Some compounds exhibit a high affinity for the enzyme's active site, competing with natural substrates for binding and subsequently obstructing the enzyme's catalytic function. Allosteric inhibitors, on the other hand, induce conformational changes in the enzyme's structure, effectively perturbing its ability to synthesize DNA with precision. In both cases, the consequence is a discernible deceleration or outright stalling of DNA synthesis when encountering UV-induced lesions, as DNA polymerase η's typical efficiency is significantly compromised.
Consequently, the cellular DNA damage response machinery is compelled to explore alternative pathways to manage the lesions, often at the expense of faithful DNA repair. These inhibitors not only offer a means to investigate the intricate interplay between translesion synthesis, replication fidelity, and DNA damage tolerance but also hold potssibility for applications in conditions where precise manipulation of DNA repair processes is desired. In conclusion, DNA polymerase η inhibitors serve as a sophisticated toolkit for dissecting the multifaceted processes that underpin DNA replication, damage response, and genome stability. By intricately disrupting the specialized activities of DNA polymerase η, these compounds offer unprecedented insights into the regulatory mechanisms governing cellular responses to UV-induced DNA damage, and they hold promise as potential agents for targeted intervention in various biological contexts.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Forms DNA adducts that distort the DNA helix, leading to polymerase stalling. | ||||||
Carboplatin | 41575-94-4 | sc-202093 sc-202093A | 25 mg 100 mg | $47.00 $132.00 | 14 | |
Similar to cisplatin, it forms DNA adducts that disrupt replication. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Non-specifically inhibits various DNA polymerases, including Pol η. |